1. Trifluoromethylation of dihydrocoptisines and the effect on structural stability and XBP1-activating activity. Xiang Li, Hai-Jing Zhang, Zhi-Hong Li, Liang-Qiu Wu*, An-Jun Deng*, Hai-Lin Qin*, Journal of. Asian Natural. Products Research, 2021, 17(7): 10.1080/10286020.2021.1935895.
2. Syntheses and Structure-Activity Relationships in Antibacterial Activity against Clostridium difficile and XBP1 Activation Property of 13-[(N-Alkylamino)methyl]-8-oxodihydrocoptisines. Jing Li, Hai-Jing Zhang, An-Jun Deng, Zhi-Hong Li, Ya-Ling Xing,* Lian-Qiu Wu,* and Hai-Lin Qin*. Chemistry Biodiversity, 2020, 17(7): e2000265.
3. Syntheses and Structure–Activity Relationships in Growth Inhibition Activity against Human Cancer Cell Lines of 12 Substituted Berberine Derivatives. Molecules, Bo Wang, An-Jun Deng*, Zhi-Hong Li, Nan Wang and Hai-Lin Qin*, 2020, 25:1871.
4. Syntheses and structure-activity relationships on antibacterial and anti-ulcerative colitis properties of quaternary 13-substituted palmatines and 8-oxo-13-substituted dihydropalmatines. Li Song, Hai-Jing Zhang, An-Jun Deng, Jia Li, Xiang Li, Zhi-Hong Li, Zhi-Hui Zhang, Lian-Qiu Wu*, Sheng-Qi Wang*, Hai-Lin Qin*, Bioorganic & Medicinal Chemistry, 2018, 26(9):2586-2598.
5. Synthesis of quaternary 8-(1-acylethene-1-yl)-13-methylcoptisine chlorides and their selective growth inhibitory activity between human cancer cell lines and normal intestinal epithelial cell-6. Zhi-Hui Zhang, Yu Yan, An-Jun Deng, Hai-Jing Zhang, Zhi-Hong Li, Tian-Yi Yuan, Lian-Hua Fang, Lian-Qiu Wu, Guan-Hua Du, Hai-Lin Qin*, Chinese Chemical Letters, 2018, 29:131-135.
6. Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis. HaiJing Zhang, ZhiHui Zhang, GuangMing Song, XiaoNan Tang, HuaChen Song, AnJun Deng, WenJie Wang, LianQiu Wu, Hailin Qin. European journal of Pharmaceutical Sciences, 2017, 109: 56-64.
7. Colitis is effectively ameliorated by (±)-8-acetonyl-dihydrocoptisine via XBP1-NF-κB pathway. HaiJing Zhang, GuangMing Song, ZhiHui Zhang, HuaChen Song, XiaoNan Tang, AnJun Deng, WenJie Wang, LianQiu Wu*, and HaiLin Qin*, Frontiers in Pharmacology, 2017, 8: 619
8. Versatile methods for synthesizing organic acid salts of quaternary berberine-type alkaloids as anti-ulcerative colitis agents. Zhi-Hui Zhang, Jing Li, Hai-Jing Zhang, An-Jun Deng, Lian-Qiu Wu*, Zhi-Hong Li, Hong-Rui Song, Wen-Jie Wang, Hai-Lin Qin*. Journal of. Asian Natural. Products Research, 2016, 18, 576-586.
9. Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Anti-ulcerative Colitis Agents Targeting XBP1. Meng Xie, Hai-Jing Zhang, An-Jun Deng, Lian-Qiu Wu*, Zhi-Hui Zhang, Zhi-Hong Li, Wen-Jie Wang, and Hai-Lin Qin*, Journal of Natural Products. 2016, 79, 775-783.
10. Synthesis and Structure-activity Relationships of Quaternary Coptisine Derivatives as Potential Anti-ulcerative Colitis Agents. Zhi-Hui Zhang, Hai-Jing Zhang, An-Jun Deng, Bo Wang, Zhi-Hong Li, Yang Liu, Lian-Qiu Wu*, Wen-Jie Wang, and Hai-Lin Qin*. Journal of Medicinal Chemistry. 2015, 58, 7557-7571.
11. New Synthetic Method of 8-Oxocoptisine Starting from Natural Quaternary Coptisine as anti-Ulcerative Colitis Agent. Zhi-Hui Zhang, Lian-Qiu Wu, An-Jun Deng, Jin-Qian Yu, Zhi-Hong Li, Hai-Jing Zhang, Weng-Jie Wang, Hai-Lin Qin, Journal of. Asian Natural. Products Research, 2014, 16(8), 841-846.
12. Syntheses and structure–activity relationships in cytotoxicities of 13-substituted quaternary coptisine derivatives. Zhi-Hui Zhang, An-Jun Deng, Lian-Qiu Wu, Lian-Hua Fang, Jin-Qian Yu, Zhi-Hong Li, Tian-Yi Yuan, Wen-Jie Wang, Guan-Hua Du, Hai-Lin Qin*, European Journal of Medicinal Chemistry, 2014, 86, 542-549.